Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic acid gel after D&C for adhesion prevention
NCT04671914Phase 4Recruiting
- Sponsor
- Institute for the Care of Mother and Child
- Start
- Sep 2021
- Primary completion
- Mar 2025
- Modality
- Polymer-based Nanoparticles, Hydrogel Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of auto-crosslinked hyaluronic acid in Intrauterine Adhesions (IUA) (2 arms), sponsored by Institute for the Care of Mother and Child. Primary endpoint: Prevalence of Intrauterine adhesions after D&C and intrauterine application of hyaluronic acid gel at 3 months. Started Sep 2021; status: recruiting.
02
Drugs
auto-crosslinked hyaluronic acid
03
Conditions
Intrauterine Adhesions (IUA)
Beyond the preview
Go deeper on NCT04671914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04671914.